Hemab Therapeutics Holdings, Inc. Common Stock Share Price
NASDAQ: COAG
Live Hemab Therapeutics Holdings, Inc. Common Stock Share Price Chart
O H L
Hemab Therapeutics Holdings, Inc. Common Stock Performance Overview
Days Range
▼
$41.45Low
$41.86High
Markets Today
| Previous Close | $41.22 |
|---|---|
| Open | $41.86 |
| Volume | 70,667 |
| Day's Range | $41.45 - $41.86 |
| 52W Range | NA |
| Market Cap | $1.91 B |
Historical Performance
| 1M Returns | -21.40 |
|---|---|
| 3M Returns | +40.97 |
| 6M Returns | NA |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Hemab Therapeutics Holdings, Inc. Common Stock Fundamentals
| Market Cap | $1.91 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $1.91 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Hemab Therapeutics Holdings, Inc. Common Stock Profit & Loss
Quarterly
| Jun 2026 | |
|---|---|
| Total Revenue + | $0 |
| Gross Profit + | $0 |
| Operating Income | -$26.08 M |
| EBITDA | -$26.00 M |
| Interest Expense | $0 |
| Depreciation | $75.00 K |
| Income Before Tax | -$24.05 M |
| Income Tax Expense | $97.00 K |
| Net Income + | -$24.15 M |
| Net Profit Margin | - |
Hemab Therapeutics Holdings, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Jun 2026 | |
|---|---|
| Share Capital | $5.00 K |
| Reserve & Surplus | -$231.44 M |
| Non-Current Liabilities | $566.00 K |
| Current Liabilities | $12.94 M |
| Total Liabilities | $13.51 M |
| Fixed Assets | $596.00 K |
| Current Assets | $464.00 M |
| Total Assets | $467.78 M |
Hemab Therapeutics Holdings, Inc. Common Stock Cash Flow
Quarterly
| Jun 2026 | |
|---|---|
| Net Income | -$24.15 M |
| Operating Cash Flow | -$22.64 M |
| Investing Cash Flow | -$107.44 M |
| Financing Cash Flow | $317.58 M |
| Change in Cash | $187.51 M |
Hemab Therapeutics Holdings, Inc. Common Stock Return Calculator
The Hemab Therapeutics Holdings, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Hemab Therapeutics Holdings, Inc. Common Stock
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
Popular Stocks
FAQs
What is the share price of Hemab Therapeutics Holdings, Inc. Common Stock today?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) share price as of September 18, 2026 is $41.80. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Hemab Therapeutics Holdings, Inc. Common Stock?
Yes, Indian Investors can invest in the Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Share by opening an international trading account with Angel One.
How can I purchase Hemab Therapeutics Holdings, Inc. Common Stock shares in India?
Purchasing Hemab Therapeutics Holdings, Inc. Common Stock (COAG) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Hemab Therapeutics Holdings, Inc. Common Stock (COAG) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Hemab Therapeutics Holdings, Inc. Common Stock?
Yes, you can purchase fractional shares of Hemab Therapeutics Holdings, Inc. Common Stock (COAG) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Hemab Therapeutics Holdings, Inc. Common Stock?
The market capitalization of Hemab Therapeutics Holdings, Inc. Common Stock on September 18, 2026, is $1.91 B.
In which sector Hemab Therapeutics Holdings, Inc. Common Stock belongs?
Hemab Therapeutics Holdings, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Hemab Therapeutics Holdings, Inc. Common Stock stocks?
In order to invest in Hemab Therapeutics Holdings, Inc. Common Stock (COAG) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
